Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nkarta Inc (NKTX)

Nkarta Inc (NKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nkarta Inc 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 USA

www.nkartatx.com Employees: 157 P: 925-407-1049

Sector:

Medical

Description:

Nkarta Inc. is a biopharmaceutical company. It develops and commercializes cell therapies for cancer treatment. The company's product candidate includes NKX101 and NKX019, which are in clinical stage. Nkarta Inc. is based in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 144,901
Enterprise Value, $K 117,031
Shares Outstanding, K 71,030
Float, K 65,063
% Float 91.60%
Short Interest, K 10,851
Short Float 15.28%
Days to Cover 16.58
Short Volume Ratio 0.31
% of Insider Shareholders 8.40%
% of Institutional Shareholders 80.54%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -108,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,720 K
EBIT, $ -121,960 K
EBITDA, $ -119,720 K

Growth:

1-Year Return -18.07%
3-Year Return -61.65%
5-Year Return -95.89%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/10/25
Next Earnings Date 03/25/26
Earnings Per Share ttm -1.38
EPS Growth vs. Prev Qtr 6.45%
EPS Growth vs. Prev Year 25.64%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NKTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -27.69%
Return-on-Assets % -22.22%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.41
Book Value/Share 4.76
Interest Coverage -2.46
60-Month Beta 0.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar